Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 8, 1996, Pages 695-701

  Hæger, Magnus ^a   Unander, Margareta ^a   Andersson, Bengt ^a   Tarkowski, Andrej ^a   Arnestad, Jan Petter ^a   Bengtsson, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Complement activation; HELLP; Interleukin 6; Preeclampsia; Tumor necrosis factor

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C5A; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DELIVERY; DOSE RESPONSE; FEMALE; HELLP SYNDROME; HUMAN; MACROPHAGE; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0029998517     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609065729     Document Type: Article

References (35)

1. Ferris TF. Toxemia and hypertension. In: Burrow GN, Ferris TF, eds. Medical complications during pregnancy. Philadelphia: WB Saunders, 1982: 1-25.
2. Houwert-de-Jong MH, Claas FHJ, Gmelig-Meyling RM et al. Humoral immunity in normal and complicated pregnancy. Eur J Obstet Gynecol Reprod Biol 1985; 19: 205-14.
3. Haeger M, Unander M, Bengtsson A. Complement activation in relation to development of preeclampsia. Obstet Gynecol 1991; 78: 46-9.
4. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule. VCAM-1; is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol 1994; 101: 485-7.
5. desArg on neutrophil function. Immunopharmacology 1980; 2: 201-19.
6. Hänsch GM, Seitz M, Betz M. Effect of the late complement components C5b-9 on human monocytes: Release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol 1987; 82: 317-20.
7. Wallenburg HCS, Dekker GA, Makowitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1-3.
8. Haeger M, Unander M, Norder-Hansson B, Tylman M, Bengtsson A. Complement, neutrophil and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 1992; 79: 19-26.
9. Goodman MG, Chenoweth DE, Weigle WO. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J Exp Med 1982; 1156: 912-7.
10. Scholz W, McClurg MR, Cardenas GJ et al. C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 1990; 57: 297-307.
11. Mason MJ, Van Epps DE. In vivo neutrophil emigration in response to interleukin-1 and tumor necrosis factor-alpha. J Leukoc Biol 1989; 45: 62-8.
12. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction. Obstet Gynecol 1994; 84: 937-40.
13. Austgulen R, Liabakk N-B, Lien E, Espevik T. Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns. Pediatr Res 1993; 33: 82-7.
14. Hugli TE, Chenoweth DE. Biologically active peptides of complement: Techniques and significance of C3a and C5a measurements. In: Nakamura RM ed. Future perspective in clinical laboratory immunoassays. New York: Alan L Liss Inc. 1980. 443-59.
15. Mollnes TE, Lea T, Froland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22: 197-202.
16. Landsdorp PM, Aarden L, Calafat J, Zeijlemaker WP. A growth factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 1986; 132: 105-113.
17. Trollmo C, Carlsten H, Tarkowski A. Intra-articular immunization induces strong systemic immune response in humans. Clin Exp Immunol 1990; 82: 384-9.
18. Buyalos RP, Rutanen E-M, Tsui E, Halme J. Release of tumor necrosis factor alpha by human peritoneal macrophages in response to toxic shock syndrome toxin-1. Obstet Gynecol 1991; 78: 182-6.
19. Arend WP, Massoni RJ, Niemann MA, Giclas PC. Absence of induction of IL-I production in human monocytes by complement fragments. J Immunol 1989; 142: 173-8.
20. Schindler R, Lonnemann G, Shaldon S, Koch K-M, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93.
21. Bradley JW. Distribution-free statistical tests. London: Prentice-Hall, 1968, 68-86.
22. Pacher R, Redl H, Frass M, Petzl DH, Schuster E, Woloszczuk W. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 1989; 17: 221-6.
23. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990; 4: 2860-7.
24. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10: 370-5.
25. Mitchell M, Lundin-Schiller S, Edwin S. Endothelin production by amnion and its regulation by cytokines. Am J Obstet Gynecol 1991; 165: 120-4.
26. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752-9.
27. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20-5.
28. Opsjön S-L, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169: 397-404.
29. Sunder-Plassmann G, Derfler K, Wagner L et al. Increased serum activity of interleukin-2 in patients with preeclampsia. J Autoimmun 1989; 2: 203-5.
30. Schröcksnadel H, Herold M, Steckel-Berger G, Fuchs D, Wachter H, Dapunt O. Zellvermittelte Immunität bei schwangerschaftsinduzierten Hochdruckerkrankungen (Cell-mediated immunity in hypertensive disorders of pregnancy). Geburtshilfe Frauenheilkd 1992; 52: 592-5.
31. Opsjön S-L, Austgulen R, Waage A. Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders. Acta Obstet Gynecol Scand 1995; 74: 19-26.
32. Tedesco F, Radillo O, Candussi G, Nazzaro A, Mollnes TE, Pecorari D. Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clin Exp Immunol 1990; 80: 236-40.
33. Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin 6 in preterm labor. J Clin Invest 1990; 85: 1392-400.
34. Bengtsson A, Heideman M. Altered anaphylatoxin activity during induced hypoperfusion in acute and elective abdominal aortic surgery. J Trauma 1986; 26: 631-6.
35. Jablons DM, Mulex́ JJ, McIntosh JK et al. IL-6/IFN-ß-2 as a circulating hormone. J Immunol 1989; 142: 1542-7.